Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Clinical TrialArtificial Intelligence

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1798373

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1798373

Clinical Intelligence

PUBLISHED:
PAGES: 213 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Clinical Intelligence Market to Reach US$3.6 Billion by 2030

The global market for Clinical Intelligence estimated at US$1.6 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 16.5% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Hardware Component segment is estimated at 11.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$408.8 Million While China is Forecast to Grow at 13.8% CAGR

The Clinical Intelligence market in the U.S. is estimated at US$408.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$548.0 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.8% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Clinical Intelligence Market - Key Trends & Drivers Summarized

How Is Clinical Intelligence Transforming Healthcare Decision-Making Worldwide?

The global clinical intelligence market is undergoing a radical transformation, becoming an integral pillar of the evolving healthcare landscape. As healthcare systems around the world grapple with data overload, rising patient volumes, and growing demand for personalized care, clinical intelligence is emerging as a vital tool to translate raw data into actionable insights. This technology harnesses big data analytics, machine learning algorithms, natural language processing, and real-time patient data integration to provide clinical decision support, improve patient outcomes, and reduce operational inefficiencies. Its applications extend from predictive modeling and risk stratification to population health management and clinical workflow optimization. Governments and health agencies in regions such as North America, Europe, and Asia-Pacific are increasingly integrating clinical intelligence into public health initiatives to enhance value-based care delivery. Notably, the rapid digitization of healthcare records, with electronic health records (EHR) and interoperable systems gaining traction, is significantly accelerating adoption. Moreover, the focus on patient-centric models has created a pressing need for advanced tools that can bridge the information gap between diagnosis and treatment pathways. The ability of clinical intelligence platforms to analyze vast datasets and deliver real-time, evidence-based recommendations is propelling their role in shaping precision medicine, thus transforming both acute and chronic care management.

Why Are Hospitals and Healthcare Providers Rapidly Adopting Clinical Intelligence Solutions?

The demand for clinical intelligence among hospitals and healthcare providers is escalating, primarily driven by the need to streamline clinical workflows, reduce costs, and enhance care quality. As healthcare institutions shift from volume-based to value-based care, they require more advanced, integrated platforms capable of supporting complex decision-making and predictive analytics. Clinical intelligence systems are now being deployed to improve diagnostic accuracy, monitor patient outcomes, and facilitate early intervention by identifying high-risk patients through advanced stratification models. Hospitals are also utilizing these systems to optimize resource utilization, from staffing to bed management, thereby improving operational efficiency. Furthermore, with healthcare providers under increasing regulatory scrutiny, clinical intelligence aids in compliance by automating documentation, coding, and adherence to clinical guidelines. Many academic medical centers and large hospital systems are embedding intelligence tools into EHR platforms to deliver point-of-care insights, reduce errors, and shorten the diagnostic journey. Additionally, the pressure to demonstrate measurable outcomes is pushing institutions to adopt clinical intelligence as a strategic differentiator. The integration of real-time monitoring tools with AI-driven analytics is enhancing the timeliness and accuracy of treatment plans, while facilitating seamless communication across multidisciplinary teams. This is particularly crucial in intensive care units (ICUs), emergency departments, and oncology settings where time-sensitive decisions are critical. The market is witnessing a surge in collaborations between healthcare IT vendors and hospitals to co-develop tailored clinical intelligence systems that can cater to specific institutional needs.

Could Regulatory Frameworks and Data Security Concerns Hinder or Accelerate Market Growth?

While clinical intelligence offers transformative benefits, its growth trajectory is shaped significantly by regulatory frameworks, data governance, and cybersecurity challenges. Regulatory bodies such as the FDA in the United States and the EMA in Europe are actively working to define standards for the deployment of AI and analytics in clinical decision-making. These regulations, although necessary, introduce complexities in software development cycles and compliance protocols. On the one hand, stringent regulations may delay the approval and integration of new solutions; on the other hand, they offer a structured pathway for scalable and ethical innovation. The increasing emphasis on patient data privacy, especially under frameworks like HIPAA, GDPR, and various national health information acts, requires that clinical intelligence platforms incorporate robust encryption, anonymization, and auditability features. Security remains a top concern for healthcare organizations due to the sensitive nature of clinical data and the growing frequency of cyberattacks targeting hospitals and health systems. In response, many vendors are enhancing their platforms with advanced security layers and real-time monitoring to ensure regulatory compliance and instill user trust. At the same time, the growing reliance on cloud infrastructure introduces both opportunities and risks. While cloud-based platforms improve scalability, real-time access, and cost-effectiveness, they also demand rigorous security protocols. Interestingly, governments and health ministries are increasingly funding digital health initiatives and allocating budgets toward the development of secure, compliant infrastructure that supports clinical intelligence. These investments are contributing to a more standardized and secure ecosystem that is conducive to long-term market expansion.

What Is Fueling the Rise of the Clinical Intelligence Market Across Industries and Geographies?

The growth in the clinical intelligence market is driven by several factors rooted in technological advancements, shifting healthcare delivery models, evolving consumer expectations, and increased cross-sector collaboration. The rapid adoption of artificial intelligence, deep learning, and big data analytics in healthcare IT is creating a strong foundation for clinical intelligence tools to flourish. Advances in natural language processing are enabling better extraction of insights from unstructured data such as physician notes, radiology reports, and clinical transcripts. In parallel, the rise of interoperable platforms and Health Information Exchanges (HIEs) is allowing seamless data sharing across departments and institutions, thereby enhancing the utility of analytics tools. On the end-user front, the expanding footprint of ambulatory care centers, diagnostic labs, and specialized clinics is boosting demand for scalable clinical intelligence systems tailored for specific use cases. Furthermore, the increasing prevalence of chronic diseases, coupled with aging populations in developed and developing nations alike, is necessitating proactive, data-driven approaches to care delivery. Consumer behavior is also shifting, with patients expecting more personalized, transparent, and timely care - expectations that clinical intelligence is uniquely positioned to meet. Pharmaceutical companies are increasingly leveraging clinical intelligence for real-world evidence generation, clinical trial optimization, and drug safety monitoring, creating additional demand streams. Finally, strategic collaborations between tech giants and healthcare providers, alongside funding from venture capital and public-private partnerships, are facilitating faster innovation cycles and wider market penetration. These converging factors are not only propelling the market forward but also reshaping the healthcare paradigm toward one that is increasingly predictive, preventive, and precision-oriented.

SCOPE OF STUDY:

The report analyzes the Clinical Intelligence market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software Component, Hardware Component, Services Component); Type (Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System, Other Types); Application (Revenue Cycle Management Claims Application, Supply Chain Application, Fraud Application, Other Applications); End-Use (Hospitals End-Use, Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • Ada Health
  • Allscripts
  • Beamtree
  • Cerner Corporation
  • Cerner Enviza
  • Cognizant
  • Datavant
  • EClinicalWorks
  • Epic Systems Corporation
  • GE HealthCare
  • H1 Inc.
  • IBM
  • ICON plc
  • McKesson Corporation
  • Medidata Solutions
  • Philips (Clinical layer)
  • QSI Management LLC
  • Siemens Healthineers
  • TruBridge
  • UnitedHealth Group
  • Veradigm

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP38633

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Clinical Intelligence - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • AI-Powered Diagnostics Propel Growth in Real-Time Clinical Intelligence Platforms
    • Shift Toward Value-Based Care Expands Addressable Market for Predictive Health Analytics
    • Here's How Population Health Management Is Driving Demand for Longitudinal Patient Data Insights
    • Rising Chronic Disease Burden Strengthens the Business Case for Integrated Clinical Decision Support Systems
    • Surge in Virtual Care Models Accelerates Demand for Remote Patient Monitoring and Risk Stratification Tools
    • Clinical Workflow Optimization Needs Drive Adoption of Intelligent Automation in EHR Ecosystems
    • Here's the Story: How Clinician Burnout Is Fueling Growth in AI-Supported Decision Workflows
    • Precision Medicine Initiatives Generate Demand for Genomic and Biomarker-Driven Intelligence Layers
    • Digital Therapeutics Integration Expands the Role of Clinical Intelligence in Personalized Care Pathways
    • Advanced Imaging and Diagnostic Modalities Strengthen Demand for Multimodal Data Aggregation Tools
    • Cybersecurity Concerns and Data Governance Requirements Spur Development of Secure Clinical Intelligence Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Clinical Intelligence Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Clinical Intelligence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Clinical Intelligence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Supply Chain Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Supply Chain Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Fraud Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Fraud Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Revenue Cycle Management Claims Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Revenue Cycle Management Claims Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Population Health Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Population Health Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Retrospective Performance Management & Predictive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Retrospective Performance Management & Predictive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Clinical Benchmarking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Clinical Benchmarking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Clinical Decision Support System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Clinical Decision Support System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • CANADA
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • JAPAN
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • CHINA
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 58: China Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • EUROPE
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Clinical Intelligence by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • FRANCE
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 76: France Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • GERMANY
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • UNITED KINGDOM
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 100: UK Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Clinical Intelligence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Clinical Intelligence by Component - Software Component, Hardware Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Clinical Intelligence by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Services Component for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Clinical Intelligence by Application - Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Clinical Intelligence by Application - Percentage Breakdown of Value Sales for Supply Chain Application, Fraud Application, Other Applications and Revenue Cycle Management Claims Application for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Clinical Intelligence by End-Use - Hospitals End-Use, Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Clinical Intelligence by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Clinical Intelligence by Type - Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Clinical Intelligence by Type - Percentage Breakdown of Value Sales for Population Health Management, Retrospective Performance Management & Predictive Analytics, Clinical Benchmarking, Clinical Decision Support System and Other Types for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!